Understanding the genomic landscape of blood cancer
Immunotherapies hold promise as the holy grail for cancer treatment, but patient responses to these interventions are often variable in solid tumors and blood cancers. In this episode, Iris Kulbatski from The scientistThe Creative Services team spoke to Olli Dufva, a physician and doctoral researcher at the Hematology Research Unit of the University of Helsinki, about his work analyzing the genomic landscape of hematological cancers. By combining next-generation techniques with traditional methods such as flow cytometry, he aims to better understand the complex range of immune characteristics in different cancer subtypes and use this data to predict patient outcomes.
LabTalk is a special edition podcast produced by The scientist’s Creative Services Team, where we explore topics at the forefront of innovative research. This month’s episode is sponsored by Sartorius.
Olli Dufva, MD
Doctor and Doctoral Researcher
Hematology Research Unit Helsinki
Translational Immunology Research Program
University of Helsinki
The Sartorius Group is a leading international partner for biopharmaceutical research and industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services division focuses on the needs of laboratories performing research and quality control in pharmaceutical and biopharmaceutical companies and those of academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focused on single-use solutions, helps customers manufacture biotechnology drugs and vaccines safely and efficiently.